Impact on Survival of Durvalumab +/- Olaparib Investigated in Endometrial Cancer
July 30th 2021
In an interview with Targeted Oncology™, Shannon N. Westin, MD, MPH, FACOG, discussed the DUO-E trial, its design, end points, and the need for novel endometrial cancer therapies.